J&J Report Strong Second Quarter Results

Johnson & Johnson have reported strong results for their second quarter of 2013, with an 8.5% increase in sales.  The increase was aided by robust results from their prostate cancer drug, Zytiga. Net income reached $3.83 billion, a major increase from the $1.41 billion from the previous year’s quarter 2 period, aided by the gain

Continue Reading

AstraZeneca announces new Cambridge Biomedical Campus

Pharmaceutical giant AstraZeneca has announced it is setting up its new global headquarters, just south of Cambridge. The £330million research and development site will employ a skilled workforce of 2,000 people and will open by 2016. Research and Development will cease at Alderley Park in Cheshire and close its London headquarters. Many of these posts will

Continue Reading

If 8 areas of NHS activity were improved then vast amounts of money for CCGS could be saved

If the National Health Service improved just 8 areas of their activity then 212 of England’s Clinical Commissioning Groups (CCGs) would save more than £1.6 billion. Statistics were analysed in research by consultancy MedeAnalytics. This covers all patient-level activity and associated costs taking place in hospitals in England. From analysis, researchers have narrowed down 8

Continue Reading

Icon Release Strong Q1 Results

Icon continued their run of solid quarterly results, reporting an operating income of US $23.0 million, an increase of 96.0% year on year.  Net revenues were also higher, at US $316.8 million. The income total included reorganisation, and other items amounting to US $4.41 million.  Without these charges operating income was up to US $27.4

Continue Reading

European Pharmaceutical 2013 Salary Survey

Do you earn the correct amount? As part of the Clinical Professionals Group, Only Medics are launching a European salary survey to determine the salary and benefits for European pharmaceutical physicians. The salary survey consists of questions concerning your career and how satisfied you are with your current salary, and will only take a few minutes to

Continue Reading